RSV in transplant and immunocompromised patients.

IF 3.4 4区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cleveland Clinic Journal of Medicine Pub Date : 2024-09-04 DOI:10.3949/ccjm.91.s1.06

Christine E Koval, Blanca E Gonzalez

引用次数: 0

Abstract

Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.

查看原文本刊更多论文

移植和免疫力低下患者中的 RSV。

呼吸道合胞病毒（RSV）是导致婴儿、老年人和免疫力低下患者发病和死亡的重要原因。疾病的严重程度因潜在的免疫学病理而异，从上呼吸道疾病发展到下呼吸道疾病时，结果会更差。在这篇综述中，我们探讨了 RSV 对免疫力低下人群的影响，并讨论了有限的可用治疗方法以及较新的 RSV 预防策略对免疫力低下的成人和儿童的潜在影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cleveland Clinic Journal of Medicine 医学-医学：内科

CiteScore

3.80

自引率

0.00%

发文量

109

审稿时长

6-12 weeks

期刊介绍： The mission of Cleveland Clinic Journal of Medicine (CCJM) is to provide its readers with up-to-date, practical, clinical information relevant to internal medicine, cardiology, and related fields. Consistent with this mission, CCJM focuses on timely review articles and other content that has a continuing-education orientation rather than on original research or case reports. CCJM authors, drawn from Cleveland Clinic and other top medical institutions throughout the world, are asked to identify new findings that are changing the practice of medicine and to advise readers how to apply them in daily patient care. Authors are chosen for their experience, acquired through caring for patients, teaching other physicians, and researching clinical questions.